What if your doctor could tell you what your risk was for heart disease and stroke, without using needles or blood work, and that no invasive or expensive testing was required? What if the answer to diagnosing heart disease could actually be right at the tip of your finger?
That’s now possible with the EndoPAT™, an innovative diagnostic tool that gives doctors and patients a window to the current functioning of the endothelium and the overall health of the heart. The endothelium is the thin layer of flat, smooth cells that line the inner walls of the 62,000 miles of blood vessels that snake their way throughout the body.
EndoPAT has several advantages
- It’s the only medical device indicated for use in endothelial function assessment
- It is non-invasive. A standard blood pressure cuff and finger probes are easily put on and removed
- Testing is quick and easy. The doctor can complete an EndoPAT test in the office in 15 minutes
- The device provides reliable and reproducible results. EndoPAT tests have provided important clinical information in more than 100 peer-reviewed publications
- Accurately assesses the health of the heart. Growing scientific literature includes more than 100 EndoPAT publications in peer-reviewed abstracts and journals presented in major conferences
- EndoPAT is FDA approved (2003) and CE marked
- Over 400 EndoPAT devices are now in use in over 40 countries
Who should have an EndoPAT test?
The earlier you diagnose a cardiac condition and initiate a cardio-protective program, the better off you are. Candidates include men between the ages of 40 and 70 and women between the ages of 50 to 70 with one or more of the following risk factors for heart disease:
- Cigarette smoking
- Elevated cholesterol level
- Family history of heart disease (sudden death, heart attack, or need for angioplasty or bypass surgery) in a first-degree male relative (parents or siblings) 55 years old or less, or a first-degree female relative 65 years old or less
- High blood pressure
- Sedentary life style
Individuals with multiple risk factors, or one particularly severe risk factor, need to talk to their physician about earlier intervention. For example, for a 35-year-old male whose father died at the age of 41 of a heart attack, an EndoPAT test would be warranted. There are many such risk factors and the test is supported by multiple IDC-9 codes.